Therapeutic indications
Aclarubicin is indicated for:
Acute leukemias
at least one of
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Acute monocytic leukaemia
Acute megakaryoblastic leukaemia
Acute leukaemia of unspecified cell type
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Contraindications
Aclarubicin is contraindicated in the following cases:
Pre-existing heart disorder
at least one of
Chronic rheumatic heart diseases
Ischaemic heart diseases
Other forms of heart disease